UK: AstraZeneca has announced that Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or refractory disease in whom asthma symptoms cannot.
Tezspire approved in Japan for the treatment of severe asthma astrazeneca.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from astrazeneca.com Daily Mail and Mail on Sunday newspapers.
The Japanese government currently has no plans to impose restrictions amid the seventh wave of coronavirus infections, but it remains to be seen whether the medical system will be able to endure the cost of this decision.
Japan's daily COVID-19 cases top 100,000 for the third straight day cgtn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cgtn.com Daily Mail and Mail on Sunday newspapers.